A bid to change the grandfathering date of the U.S. Food and Drug Administration’s deeming regulations may not make it into the appropriations bill that faces an imminent deadline in Congress.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.